Management Strategies
for Complex Crohn’s Disease:
Medical vs. Surgical Approach

The Webcast Series presented by the Digestive Disease Institute gives in-depth clinical perspectives on the advantages and disadvantages of surgical and medical treatment of Crohn’s disease in a case-based format. It also highlights major strategies for when and how medical versus surgical therapy should be instituted.

Target Audience

The webcast series is directed to gastroenterologists, colorectal surgeons, primary care internists, family practitioners, nurses, nurse practitioners, and other associated healthcare professionals who treat IBD and Crohn’s disease and who want to understand the full range of treatment options for this patient population.

	Advances in Medical Therapy for Crohn's Disease
	Estimated Time: 15 minutes Release Date: September 24, 2009 Type: Webcast	Technical Requirements: Windows Media Expiration Date: September 24, 2011 Specialties: Family Practice, Gastroenterology, Internal Medicine & Subspecialties, Nursing, Surgery
	Advances in Surgical Treatments for Crohn's Disease
	Estimated Time: 15 minutes Release Date: September 24, 2009 Type: Webcast	Technical Requirements: Windows Media Expiration Date: September 24, 2011 Specialties: Family Practice, Gastroenterology, Internal Medicine & Subspecialties, Nursing, Surgery
	Management Strategies for Complex Crohn's Disease Case Presentations
	Estimated Time: 1 hour 30 minutes Release Date: September 24, 2009 Type: Webcast	Technical Requirements: Windows Media Expiration Date: September 24, 2011 Specialties: Family Practice, Gastroenterology, Internal Medicine & Subspecialties, Nursing, Surgery

Series Objectives

After completing this series, the participant will be able to do the following:

1. Summarize the most up-to-date information on advances in medical therapy, particularly anti-TNF-alpha agents, and surgical therapy, such as bowel-reserving stricturoplasty, for patients with moderate to severe Crohn’s disease;
2. Discuss the current evidence on the potential benefits and risks for medical versus surgical therapies for these patients;
3. Create an evidence-based management strategy that optimizes the medical and surgical therapy in a patient;
4. Describe a management plan that minimizes medical and surgical adverse sequelae of the selected therapies;
5. Identify strategies for building alliances between gastroenterologists and colorectal surgeons.

Activity Directors